Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-12-10

FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved ANI Pharmaceuticals' original application for a generic omeprazole and sodium bicarbonate combination product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omeprazole and sodium bicarbonate (omeprazole and sodium bicarbonate)

Snippet

ORIG AP for OMEPRAZOLE AND SODIUM BICARBONATE (OMEPRAZOLE AND SODIUM BICARBONATE)